机构

• 合肥物质科学研究院 [27]
• 上海药物研究所 [22]
• 自动化研究所 [12]
• 金属研究所 [1]
• 上海生物化学与细胞生... [1]

采集方式

• OAI收割 [63]

内容类型

• 期刊论文 [62]
• 专著章节 [1]

发表日期

• 2023 [8]
• 2022 [20]
• 2021 [13]
• 2020 [13]
• 2019 [6]
• 2018 [2]
• 更多

学科主题

• Oncology [1]

筛选

浏览/检索结果: 共63条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Tumor Mutation Burden-Related Histopathologic Features for Predicting Overall Survival in Gliomas Using Graph Deep Learning 期刊论文  OAI收割 AMERICAN JOURNAL OF PATHOLOGY, 2023, 卷号: 193, 期号: 12, 页码: 2111-2121 作者:  Sun, Caixia;  Luo, Tao;  Liu, Zhenyu;  Ge, Jia;  Shao, Lizhi   |  收藏  |  浏览/下载：5/0  |  提交时间：2024/02/22 Design and synthesis of 1H-pyrazolo[3,4-d]pyrimidine derivatives as hematopoietic progenitor kinase 1 (HPK1) inhibitors 期刊论文  OAI收割 BIOORGANIC CHEMISTRY, 2023, 卷号: 140, 页码: 18 作者:  Zhang, Junjie;  Li, Yan;  Tang, Haotian;  Zhou, Qianqian;  Tong, Linjiang   |  收藏  |  浏览/下载：8/0  |  提交时间：2023/12/08 Cancer immunotherapy  HPK1  Structure -based design  HPK1 inhibitor   Carbohydrate Strengthens the Immunotherapeutic Effect of Small-Molecule PD-L1 Inhibitors 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 66, 期号: 11, 页码: 7179-7204 作者:  Dong, Qian;  Tong, Mengya;  Yu, Xiaolu;  Wang, Lei;  Ao, Jiwei   |  收藏  |  浏览/下载：15/0  |  提交时间：2023/10/17 Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expression 期刊论文  OAI收割 JOURNAL OF CLINICAL INVESTIGATION, 2023, 卷号: 133, 期号: 9, 页码: 12 作者:  Wang, Xiaobo;  Huang, Jing;  Liu, Fenglin;  Yu, Qian;  Wang, Ruina   |  收藏  |  浏览/下载：19/0  |  提交时间：2023/10/17 Development of a series of quinazoline-2,5-diamine derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 248, 页码: 20 作者:  Shi, Huanyu;  Tang, Haotian;  Li, Yan;  Chen, Danqi;  Liu, Tongchao   |  收藏  |  浏览/下载：19/0  |  提交时间：2023/04/10 Cancer immunotherapy  SAR study  HPK1 inhibitors  Quinazoline-2  5-diamine  IL-2 production   Suppression of Tumor or Host Intrinsic CMTM6 Drives Antitumor Cytotoxicity in a PD-L1-Independent Manner 期刊论文  OAI收割 CANCER IMMUNOLOGY RESEARCH, 2023, 卷号: 11, 期号: 2, 页码: 241-260 作者:  Long, Yiru;  Chen, Runqiu;  Yu, Xiaolu;  Tong, Yongliang;  Peng, Xionghua   |  收藏  |  浏览/下载：1/0  |  提交时间：2024/03/27 A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity 期刊论文  OAI收割 MOLECULAR THERAPY, 2023, 卷号: 31, 期号: 1, 页码: 66-77 作者:  Shi, Wenqiang;  Lv, Liangyin;  Liu, Nan;  Wang, Hui;  Wang, Yang   |  收藏  |  浏览/下载：22/0  |  提交时间：2023/04/10 Combined Use of Immune Checkpoint Inhibitors and Phytochemicals as a Novel Therapeutic Strategy against Cancer 期刊论文  OAI收割 JOURNAL OF CANCER, 2023, 卷号: 14, 期号: 12, 页码: 2315-2328 作者:  Luo, LingJie;  Lin, Caiji;  Wang, Pengfei;  Cao, Danli;  Lin, Yiru   |  收藏  |  浏览/下载：11/0  |  提交时间：2023/10/17 Immune checkpoint inhibitor  Phytochemicals  Combination therapy  Immune-related adverse events  Predictive biomarker  Gut microbiota   PD-L1 Aptamer-Functionalized Metal-Organic Framework Nanoparticles for Robust Photo-Immunotherapy against Cancer with Enhanced Safety 期刊论文  OAI收割 ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2022, 页码: 9 作者:  Zhang, Jingfang;  Li, Wenzhe;  Qi, Yafei;  Wang, Guorong;  Li, Lele   |  收藏  |  浏览/下载：12/0  |  提交时间：2023/02/22 DNA Nanotechnology  Immunotherapy  Metal-Organic Frameworks  PD-L1 Aptamer  Spherical Nucleic Acids (SNAs)   Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors 期刊论文  OAI收割 BMC Medicine, 2022, 卷号: 20, 期号: 1 作者:  Zhang,Pei;  Du,Yang;  Bai,Hua;  Wang,Zhijie;  Duan,Jianchun   |  收藏  |  浏览/下载：19/0  |  提交时间：2022/11/21 Tucidinostat  Tumor microenvironment  PD-L1  CCL5  Solid tumor